On the stock market since 2024, it operates in the world of money and finance. It has 780 employees. Now — the numbers.
The company is still in the product-building phase: its spending runs above its sales. That only changes once the product starts selling at scale.
That much dependence is a risk in itself: if this one line weakens, the whole company feels it directly.
Average growth of 10% a year over the last 3 years. Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. For now, time is on the company’s side.
Executives buying with their own money is usually read as confidence in the company’s future.
An investor who bought at the very peak is down 98% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
Over the last 3 years, sales grew about 10% a year on average.
Sales run at $281.1M a year. A small number, but proof the product has real buyers.
Over the last 12 months, company executives reported 43 buys and 6 sells. Management buying with its own money is usually read as a good sign.
A loss of $8.8M against $281.1M in annual sales.
Since the drop from its peak, buyer appetite hasn’t come back.
On our five-subject report card, SMST sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: SMST is a high-risk stock — not yet profitable, and its future rides on its product catching on.